Rammurti Kamble

Rammurti Kamble

Hematology | Internal Medicine
6565 Fannin St
Ste A6-080
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: January 14, 2026

CD19-directed CAR T therapy for intravascular large B-cell lymphoma.

CD19-directed CAR T therapy for intravascular large B-cell lymphoma.

Journal: Haematologica
Published: August 21, 2025

Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience.

Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience.

Journal: JHLT open
Published: July 21, 2025

Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.

Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.

Journal: Transplantation and cellular therapy
Published: May 28, 2024

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation
Published: January 26, 2024

Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.

Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.

Journal: The Lancet. Child & adolescent health
Published: December 04, 2023

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation
Published: August 24, 2023

Extended duration letermovir in allogeneic hematopoietic stem cell transplant.

Extended duration letermovir in allogeneic hematopoietic stem cell transplant.

Journal: Transplant immunology
Published: March 16, 2023

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

Journal: The New England journal of medicine
Published: June 06, 2022

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

Journal: JAMA oncology
Published: January 13, 2022

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.

Journal: Transplantation and cellular therapy
Published: January 06, 2022

Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.

Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.

Journal: Blood
Published: November 03, 2021
Showing 1-12 of 134

Last Updated: 09/26/2026